Computational and Mathematical Methods in Medicine / 2014 / Article / Tab 1

Research Article

Logic Regression for Provider Effects on Kidney Cancer Treatment Delivery

Table 1

Distribution of patient and tumor characteristics by surgical procedures (1995–2005).

Total LPN LRN OPN ORN value
(%) (%) (%) (%)
11,918 427 (3.6) 2082 (17.5) 1380 (11.6) 8029 (67.3)

Age at surgery (years) 0.0001
 65–69 3127 131 (4.2) 530 (16.9) 431 (13.8) 2035 (65.1)
 70–74 3423 122 (3.6) 536 (15.7) 426 (12.5) 2339 (68.3)
 75–79 3024 98 (3.2) 579 (19.2) 354 (11.7) 1993 (65.9)
 80–84 1721 59 (3.4) 300 (17.4) 139 (8.1) 1223 (71.1)
623 17 (2.7) 137 (22.0) 30 (4.8) 439 (70.5)
Race/ethnicity 0.0001
 Caucasian 9884 344 (3.5) 1757 (17.8) 1158 (11.7) 6625 (67.0)
 African-American 878 33 (3.8) 154 (17.5) 103 (11.7) 588 (67.0)
 Hispanic 719 27 (3.8) 81 (11.3) 70 (9.7) 541 (75.2)
 Other or Unknown 437 23 (5.3) 90 (20.6) 49 (11.2) 275 (62.9)
Gender 0.0001
 Male 6882 274 (3.9) 1134 (16.5) 850 (12.4) 4624 (67.2)
 Female 5036 153 (3.0) 948 (18.8) 530 (10.5) 3405 (67.6)
Marital status 0.005
 Yes 7499 294 (3.9) 1274 (17.0) 901 (12.0) 5030 (67.1)
 No 4419 133 (3.0) 808 (18.3) 479 (10.8) 2999 (67.9)
Socioeconomic status 0.0001
 Low 3808 134 (3.5) 603 (15.8) 424 (11.1) 2647 (69.5)
 Intermediate 3899 135 (3.5) 633 (16.2) 386 (9.9) 2745 (70.4)
 High 4196 158 (3.8) 846 (20.2) 568 (13.5) 2624 (62.5)
Charlson comorbidity score 0.38
 0 6842 241 (3.5) 1186 (17.3) 794 (11.6) 4621 (67.5)
 1 2847 104 (3.7) 512 (18.0) 313 (11.0) 1918 (67.4)
1904 74 (3.9) 345 (18.1) 246 (12.9) 1239 (65.1)
Tumor size (cm) 0.0001
5188 352 (6.8) 949 (18.3) 1035 (20.0) 2852 (54.9)
4 6401 51 (0.8) 1101 (17.2) 286 (4.5) 4963 (77.5)
Tumor histology 0.0001
 Clear cell 10000 301 (3.0) 1682 (16.8) 1042 (10.4) 6975 (69.8)
 Papillary 888 77 (8.7) 200 (22.5) 170 (19.1) 441 (49.7)
 Chromophobe 391 24 (6.1) 107 (27.4) 82 (21.0) 178 (45.5)
 Other 639 25 (3.9) 93 (14.6) 86 (13.5) 435 (68.1)

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.